Partial least squares Discriminant analysis on MS studies

This analysis uses the "muma" package of the R statistics environment (Reference)

Click on links below to perform analysis.

PLSDA	Study ID	Scaling	Study Title	MS Analysis Type
	ST002857	Auto Pareto Vast Median Range None	Intracerebroventricular Transplantation of Foetal Allogeneic Neural Stem Cells in Patients with Secondary Progressive Multiple Sclerosis (hNSC-SPMS): a phase I dose-escalation clinical trial - Metabolomics Analysis of Human CSF and Serum	Reversed phase POSITIVE ION MODE
	ST002857	Auto Pareto Vast Median Range None	Intracerebroventricular Transplantation of Foetal Allogeneic Neural Stem Cells in Patients with Secondary Progressive Multiple Sclerosis (hNSC-SPMS): a phase I dose-escalation clinical trial - Metabolomics Analysis of Human CSF and Serum	Reversed phase NEGATIVE ION MODE
	ST002857	Auto Pareto Vast Median Range None	Intracerebroventricular Transplantation of Foetal Allogeneic Neural Stem Cells in Patients with Secondary Progressive Multiple Sclerosis (hNSC-SPMS): a phase I dose-escalation clinical trial - Metabolomics Analysis of Human CSF and Serum	Reversed phase NEGATIVE ION MODE
	ST002857	Auto Pareto Vast Median Range None	Intracerebroventricular Transplantation of Foetal Allogeneic Neural Stem Cells in Patients with Secondary Progressive Multiple Sclerosis (hNSC-SPMS): a phase I dose-escalation clinical trial - Metabolomics Analysis of Human CSF and Serum	Reversed phase POSITIVE ION MODE
	ST002857	Auto Pareto Vast Median Range None	Intracerebroventricular Transplantation of Foetal Allogeneic Neural Stem Cells in Patients with Secondary Progressive Multiple Sclerosis (hNSC-SPMS): a phase I dose-escalation clinical trial - Metabolomics Analysis of Human CSF and Serum	Reversed phase NEGATIVE ION MODE